Posos, the French medtech company that specializes in analyzing medical prescriptions, has raised €10 million ($11 million) in a funding round led by Cap Horn, with participation from Mélusine Holding, Sofiouest, the Banque des Territoires, Captech Santé & Nord France Amorçage and AG2R La Mondiale.
Posos was founded in 2017 by Emmanuel Bilbault and Benjamin Grelié, and has developed an AI-powered tool that analyzes a prescription, detects potential drug interactions and suggests alternatives in case of any issues. The app scans and analyzes a prescription in real-time and cross-references its contents with patient data (age, weight, pathology, history) and a reference database of around 20 million documents from 220 different medical sources. The goal is to simplify and secure medical prescriptions.
The Posos solution is already being used by 85,000 healthcare professionals, including 40,000 doctors, across five countries. With the new funding, Posos plans to accelerate the development of its software in French hospitals as well as internationally.
Cap Horn is a leading French venture capital firm that invests in early-stage companies. Mélusine Holding is a French family office that invests in innovative startups. Sofiouest is a French investment company that supports the development of small and medium-sized enterprises in western France. The Banque des Territoires is a public investment bank that supports local development projects in France. Captech Santé is a French venture capital firm that specializes in healthcare investments, and Nord France Amorçage is a regional fund that invests in innovative startups in northern France. AG2R La Mondiale is a French insurance company that offers life, health and retirement insurance products.
Overall, the recent funding round will enable Posos to expand its reach and continue its mission of simplifying and securing medical prescriptions. In a world where AI is increasingly being used to improve medical outcomes, Posos is well-positioned to make an impact in the healthcare industry.
